Education
About Us
Working with TipRanks
Follow Us
Predictive Oncology Inc (POAI)
NASDAQ:POAI
POAI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.55 - $3.15
Previous CloseN/A
Volume663.11K
Average Volume (3M)2.09M
Market Cap
$10.02M
Enterprise Value$4.36M
Total Cash (Recent Filing)$162.15K
Total Debt (Recent Filing)$1.63M
Price to Earnings (P/E)―
Beta2.47
Next Earnings
Apr 08, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding7,209,701
10 Day Avg. Volume647,243
30 Day Avg. Volume2,090,854
Standard Deviation0.26
R-Squared0.07
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.67
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.43
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda-0.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
---
Bulls Say, Bears Say
Bulls Say
TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.
Bears Say
Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.
Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.
---
Ownership Overview
1.69% Insiders
1.80% Mutual Funds
0.61% Other Institutional Investors
94.86% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
POAI FAQ
What was Predictive Oncology Inc’s price range in the past 12 months?
Predictive Oncology Inc lowest stock price was $0.55 and its highest was $3.15 in the past 12 months.
What is Predictive Oncology Inc’s market cap?
Predictive Oncology Inc’s market cap is $10.02M.
When is Predictive Oncology Inc’s upcoming earnings report date?
Predictive Oncology Inc’s upcoming earnings report date is Apr 08, 2025 which is in 36 days.
How were Predictive Oncology Inc’s earnings last quarter?
Predictive Oncology Inc released its earnings results on Nov 13, 2024. The company reported -$0.48 earnings per share for the quarter, missing the consensus estimate of -$0.32 by -$0.16.
Is Predictive Oncology Inc overvalued?
According to Wall Street analysts Predictive Oncology Inc’s price is currently Overvalued.
Does Predictive Oncology Inc pay dividends?
Predictive Oncology Inc does not currently pay dividends.
What is Predictive Oncology Inc’s EPS estimate?
Predictive Oncology Inc’s EPS estimate is -0.25.
How many shares outstanding does Predictive Oncology Inc have?
Predictive Oncology Inc has 7,209,701 shares outstanding.
What happened to Predictive Oncology Inc’s price movement after its last earnings report?
Predictive Oncology Inc reported an EPS of -$0.48 in its last earnings report, missing expectations of -$0.32. Following the earnings report the stock price went up 2.532%.
Which hedge fund is a major shareholder of Predictive Oncology Inc?
Currently, no hedge funds are holding shares in POAI
---
Company Description
Predictive Oncology Inc
Predictive Oncology, Inc. engages in the manufacture and distribution of healthcare products, and provision of related services. The company offers STREAMWAY System, which is an automated system for the collection and disposal of infectious fluids from surgical and other medical procedures. It operates through the Medical Device and Consumable Products segments. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
---
POAI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Exact Sciences
―
Illumina
―
Vertex Pharmaceuticals
―
Crispr Therapeutics AG
―
Guardant Health
―
---